1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Alto Marketing Limited Logo

EKF Diagnostics Celebrates Success at MEDICA 2012

Attendance statistics highlight interest in new point-of-care tools

 
PRLog - Dec. 14, 2012 - SOUTHAMPTON, U.K. -- EKF Diagnostics’ success at MEDICA 2012 has been highlighted by a list of impressive statistics. The worldwide manufacturer of point-of-care (POC) diagnostic tools attracted numerous visitors to find out more about the 10 key products displayed on its 100m2 stand.  Generating the greatest interest was the European launch of two new POC products: the Quo-Lab (http://www.ekfdiagnostics.com/Quo-Lab_713.aspx) glycated haemoglobin (HbA1c) analyser for the affordable management of diabetes; and the STAT-SiteTM M bHB (http://www.ekfdiagnostics.com/STAT-Site_790.aspx) strip-based analyser, for highly accurate near patient testing of ketosis.

Over 200 product demos and 66 customer meetings were given to delegates to demonstrate the qualities of EKF Diagnostics’ newest POC solutions. The semi-automated, CE marked Quo-Lab analyser monitors HbA1c, which is increasingly used in the detection and management of diabetes, and provides a highly accurate, affordable and easy-to-use technology for GP surgeries, diabetes clinics and laboratories. The STAT-SiteTM M bHB has been developed for the measurement of ß-Hydroxybutyrate (bHB), the main ketone produced during ketosis, and provides a quantitative and accurate assessment of patients displaying symptoms of ketosis. This makes ketosis testing easier and more affordable in POC settings.

Nine free mini-seminars, attended by 121 delegates, outlined the benefits of using Quo-Lab and STAT SiteTM M bHB, alongside the Lactate Scout+ for lactate measurement in obstetrics, and the Hemo-Control Manager for haemoglobin analysis and data management. A range of clinical chemistry reagents were also presented by EKF product specialists, including the ß-Hydroxybutyrate (bHB) LiquiColor® Reagent System (http://www.ekfdiagnostics.com/Ketosis_805.aspx) developed by EKF subsidiary, Stanbio Laboratory, which is relied on by 13 of the USA’s top 25 diabetes and endocrinology hospitals for its rapid and reliable results.

According to Julian Baines, Group CEO, “The launch of our two new POC products for diabetes and ketosis testing at Medica this year was a tremendous success, which was reflected in the interest shown by the large number of attendees visiting our stand. We were delighted with the response to our seminar series. The seminars provided a great way to update customers Quo-Lab and STAT-Site M BHB and also brush up their knowledge on established EKF products.”

For more information please visit www.ekfdiagnostics.com.

--- End ---

Click to Share

Contact Email:
***@alto-marketing.com Email Verified
Source:EKF Diagnostics
Phone:+44 1489 557672
Zip:SO31 7AL
City/Town:Southampton - Hampshire - United Kingdom
Industry:Medical
Tags:EKF Diagnostics, medica
Shortcut:prlog.org/12043174
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share